Bactericidal/permeability increasing protein for use in a method of immunization, preferably as an adjuvant in a method of vaccination
AssigneeUniversitäT Regensburg
InventorsAndré Gessner, Sigrid Bülow
Life of this patent
Estimating the term…
Abstract
The present invention relates to bactericidal/permeability increasing protein (BPI) for use in a method of immunization of a patient, preferably as an adjuvant in a method of vaccination. The present invention also relates to a preparation comprising BPI for use in a method of immunization of a patient, and optionally an immunomodulatory agent. The present invention further relates to a process of producing a preparation including BPI for use in a method of immunization of a patient.
Claims12
A method of immunization of a patient, said method comprising administering to the patient an effective amount of bactericidal/permeability-increasing Protein (BPI)-stimulated target cells,
- wherein said method comprises administering BPI as a stimulant to target cells in vitro or ex vivo, wherein said stimulated target cells are subsequently administered to said patient in vivo, wherein the target cells are dendritic cells,
- wherein BPI stimulates the dendritic cells to produce cytokines that promote lymphoid cell responses,
- wherein said immunization prevents or treats a disease selected from chronic inflammatory diseases and graft-versus-host disease (GvHD), and/or wherein said immunization treats a cancerous disease.
Dependencies are inferred from the claim text.